ASN-3186

· Jiangsu Yahong Meditech Co., Ltd (Asieris)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASN-3186, covering 2025-01-22 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of ASN-3186 in Patients with Advanced Solid Tumors [Phase 1, Phase 2]